Merck, Medarex, and UMass' MBL Ink mAb deal; Vandy licenses cancer Rx assay to DiaTech; MolecularMD sub-licenses OHSU CML mutation test to Mayo Clinic, and more …
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.